Lv5
1330 积分 2023-10-11 加入
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
3天前
已完结
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
6天前
已完结
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
17天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
19天前
已完结
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
19天前
已完结
Discovery and saturation analysis of cancer genes across 21 tumour types
19天前
已完结
Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approach
19天前
已完结
Apo AIV and Citrulline Plasma Concentrations in Short Bowel Syndrome Patients: The Influence of Short Bowel Anatomy
24天前
已完结
皖公网安备34019202002308
